We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Liver disease induced coagulopathy
From WikEM
Contents
Background
Clinical Features
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Illness induced
- Vitamin K deficiency
- Disseminated Intravascular Coagulation (DIC)
- Liver disease induced coagulopathy
- Uremic bleeding syndrome
- Genetic
Evaluation
- PT prolongation
- Decreased synthesis of vitamin K-dependent factors (II, VII, IX, X)
- Thrombocytopenia
- Portal hypertension → congestive hypersplenism → splenic sequestration
- Fibrinolysis increased
- Due to decreased synthesis of alpha2 plasmin inhibitor
- Low fibrinogen level, mild elevation of FDP and D-dimer
Management
Lab abnormalities only (with out significant bleeding)
- Observation
Significant bleeding
- Vitamin K PO or IV
- Desmopressin
- Effective with minimal side effects
- 0.3mg/kg IV (preferred) or SC (max 20mg)
- Onset of action ~1hr, duration of action ~4-24hr
- Cryoprecipitate
- May be used to replace fibrinogen in patients with fibrinogen levels <100
- 1 bag per 10kg of body weight
- Platlets
- Aim for >50K for moderate risk procedures; >100K for high risk procedures
- FFP
- Use with caution; requires large volume of FFP to make a significant difference
- PPI/pepcid/octreotide (variceal bleed)
Disposition
See Also
References
Authors
Ross Donaldson, Neil Young, Daniel Ostermayer, Michael Holtz